Medical Devices
-
Cornerstone raises $200M to commercialize surgical robot
The financing comes 11 months after Cornerstone raised $70 million to support the launch of its device in China.
By Nick Paul Taylor • Nov. 13, 2025 -
Siemens to reduce stake in Siemens Healthineers
The decision is a “natural next step in our journey to becoming a fully independent company,” Siemens Healthineers CEO Bernd Montag said.
By Susan Kelly • Nov. 13, 2025 -
Explore the Trendline➔
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
Stereotaxis nets FDA clearance for redesigned surgical robot
The company also posted weaker third-quarter results, but CEO David Fischel said orders for the new GenesisX system, when fully launched, would outpace the rate for an older model.
By Susan Kelly • Nov. 12, 2025 -
Medtech VC funding slows in Q3: PitchBook
The lowest level of quarterly VC funding since 2023 has tempered expectations that the sector will achieve its best year since 2021.
By Nick Paul Taylor • Nov. 12, 2025 -
Laborie inks $465M deal to buy post-childbirth device from Organon
Organon tripled sales of the bleeding-control system from 2022 to 2024 and is on track to grow sales again this year.
By Nick Paul Taylor • Nov. 10, 2025 -
MMI tackles Alzheimer’s; SS Innovations advances telesurgery
MMI won FDA approval to study robotic surgery for Alzheimer’s disease. Elsewhere, SS Innovations’ CEO performed remote bypass surgery with a new console, and Procept BioRobotics’ Q3 revenue rose 43%.
By Susan Kelly • Nov. 10, 2025 -
Retrieved from Olympus on February 03, 2025
Olympus to cut 2,000 jobs in endoscopy reorganization
The workforce reduction is part of a restructuring designed to improve accountability and accelerate growth and innovation.
By Susan Kelly • Nov. 7, 2025 -
Synchron raises $200M to prepare for brain computer interface launch
The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.
By Nick Paul Taylor • Nov. 7, 2025 -
Illumina says China is lifting export ban
However, the sequencing company said it remains on China’s unreliable entity list, and it is working toward a long-term resolution of the issue.
By Susan Kelly • Nov. 6, 2025 -
Siemens Healthineers predicts tariff impact will double
The company expects to fully offset the negative effects of tariffs in the medium term.
By Nick Paul Taylor • Nov. 6, 2025 -
Zimmer CEO ‘very surprised’ by Q3 sales miss
CEO Ivan Tornos said multiple factors emerged late in the quarter that caused the shortfall.
By Elise Reuter • Nov. 5, 2025 -
Q&A
Medtronic’s Jason Fontana on ramping up renal denervation
The general manager for the business says building a market is something the medtech giant knows how to do.
By Susan Kelly • Nov. 5, 2025 -
Legislators object to proposed CMS payment changes for diabetes tech
In a letter to CMS Administrator Mehmet Oz, diabetes caucus leaders raised concerns that the agency’s proposals will reduce access to glucose monitors and insulin pumps.
By Elise Reuter • Nov. 4, 2025 -
Dexcom recalls G6 CGM app over software problem
A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to download an update.
By Elise Reuter • Nov. 4, 2025 -
Olympus further clarifies device use after serious injuries and death
The update is intended to cut the risk of endobronchial combustion that has been linked to serious injuries and one death.
By Nick Paul Taylor • Nov. 3, 2025 -
Edwards CFO Scott Ullem to exit post
Ullem, who has held the position for more than a decade, will transition to an advisory role after his replacement is named by mid-2026.
By Susan Kelly • Oct. 31, 2025 -
3 takeaways from TCT 2025
Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.
By Susan Kelly • Oct. 31, 2025 -
US to lower China tariffs as part of trade war truce
The truce also includes de-escalating other trade actions, such as China's rare earth export controls and U.S. investigations into China-linked ships.
By Philip Neuffer • Oct. 30, 2025 -
Philips receives FDA warning letter over quality issues
The notice follows inspections of three Philips facilities that found failures to meet standards for reporting complaints and corrective actions.
By Elise Reuter • Oct. 30, 2025 -
Zimmer wins FDA’s breakthrough status for tech to prevent joint infections
Integrating a controlled-release iodine layer into hip implants could reduce the rate of potentially fatal infections.
By Nick Paul Taylor • Oct. 30, 2025 -
Medline files for initial public offering
The medical and surgical products provider could reportedly raise $5 billion at a $50 billion valuation.
By Nick Paul Taylor • Oct. 30, 2025 -
CMS grants NCD for renal denervation, benefiting Medtronic, Recor
National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained FDA approval in 2023.
By Susan Kelly • Oct. 29, 2025 -
J&J partners with Nvidia on AI for kidney stone procedures
The medtech firm is using Nvidia’s technology in its Monarch robotic platform for urology.
By Elise Reuter • Oct. 28, 2025 -
Olympus execs talk about import alert, GI robot and AI
CEO Bob White and Chief Strategy Officer Gabriela Kaynor discussed the medtech company’s quality and technology priorities after a year of change.
By Elise Reuter • Oct. 28, 2025 -
Medtronic links renal denervation to 3-year blood pressure reduction
Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment after three years.
By Nick Paul Taylor • Oct. 28, 2025